Serum-soluble interleukin-2 receptors in B-cell lymphoproliferative malignancies
- 1 January 1992
- journal article
- critical commentary
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 20 (1) , 26-31
- https://doi.org/10.1002/mpo.2950200106
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- THE MULTI-SUBUNIT INTERLEUKIN-2 RECEPTORAnnual Review of Biochemistry, 1989
- Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseasesClinical Immunology and Immunopathology, 1989
- Interleukin-2: Inception, Impact, and ImplicationsScience, 1988
- High serum interleukin-2 receptor levels are related to advanced disease and a poor outcome in childhood non-Hodgkin's lymphomaBlood, 1987
- Soluble interleukin-2 receptors in the serum of patients with Hodgkin's diseaseBritish Journal of Cancer, 1987
- Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex.Proceedings of the National Academy of Sciences, 1986
- Novel Interleukin-2 Receptor Subunit Detected by Cross-Linking Under High-Affinity ConditionsScience, 1986
- The Human Interleukin-2 Receptor: Normal and Abnormal Expression in T Cells and in Leukemias Induced by the Human T-Lymphotropic RetrovirusesAnnals of Internal Medicine, 1986
- A Monoclonal Antibody 7G7/B6, Binds to an Epitope on the Human Interleukin-2 (IL-2) Receptor That is Distinct From That Recognized by IL-2 or Anti-TacHybridoma, 1985
- Prognostic significance of serum lactate dehydrogenase in malignant lymphomaCancer, 1980